Takara Bio and Resistomap forge deal to speed up global fight against superbugs

The collaboration combines Takara Bio’s large-scale testing technology with Resistomap’s data-driven AMR intelligence

Cipla receives two observations following USFDA inspection at Goa facility

The company stated that it will work closely with the regulator to address the observations within the stipulated timeframe

Indian Pharmacopoeia 2026 highlights need for stronger drug standards and global alignment

Experts highlighted that robust pharmacopoeial frameworks are essential for maintaining the quality, safety and efficacy of medicines

Experts push for preventive, equitable haemophilia care at IHC X Summit

The national platform brought together healthcare professionals, patient advocates, and stakeholders

India pushes policy action on adolescent nutrition as obesity concerns rise

ICMR-led consultation calls for stricter HFSS regulations, nutrition literacy, and healthier food environments

Burnett Homoeopathy hosts global summit at British parliament, amplifies India’s healthcare voice

4th World Homoeopathy Summit at Palace of Westminster and University of Oxford spotlights integrative healthcare and global collaboration

Rubicon forays into India's CNS segment with Rs 175.92 crore Arinna buy

Acquires 85% stake in the formulations company valued at Rs 200 crore enterprise value; founder Vivek Seth to retain 15%

India’s Biotech Moment: Eyestem CEO bets on fast-tracked cures & global breakthroughs

Dr Desai argued that the sector is undergoing a structural acceleration in how quickly science turns into treatments

India Pharma 2026 concludes with strong call for funding, infrastructure and speed to power innovation

The ninth edition of the event brought together over 800 delegates, more than 60 national and international speakers, and 20+ partner organisations across 10 sessions

FDA clears Travere’s FILSPARI for expanded use in rare kidney disease